DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: TG THERAPEUTICS, INC.
Filed: August 28, 2003
Period of Report: August 28, 2003
Accession Number: 0000950134-03-012316

View Document ↗ View on SEC.gov ↗